Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells
In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody which specifically targets a certain type of breast cancer cell.
Japan General Yukinari Kato Technology Platform Program For Advanced Biological Medicine Tohoku University International Journal Of Molecular Sciences Japan Agency For Medical Research
Source: news-medical.net